Detalhe da pesquisa
1.
Real-world outcomes in patients with first-line and second-line therapy for advanced esophageal squamous cell carcinoma.
Future Oncol
; 18(30): 3419-3433, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36098270
2.
Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer.
Breast Cancer Res Treat
; 183(1): 227-237, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32613539
3.
Review: clinical inertia in the management of chronic obstructive pulmonary disease.
COPD
; 9(1): 73-80, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22292599